U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

Buying a new pharmacy will allow Hims & Hers to expand into new markets. Hims & Hers ( HIMS -1.11%) recently acquired a ...

Volatility continues for Hims & Hers. While this week was good for the stock, shares of Hims & Hers have been all over the ...

Check the time stamp on this data. Updated AI-Generated Signals for Hims & Hers Health Inc. Class A (HIMS) available here: ...

Needham has recently initiated Hims & Hers Health Inc (HIMS) stock to Buy rating, as announced on August 22, 2024, according to Finviz. Earlier, on August 9, 2024, Imperial Capital had reduced the ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down ...

Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military ...

Hims & Hers, the telehealth company, saw its stock price range from under $6 to over $25 during the last 52 weeks. Click here ...

Last week’s 19% gain means that institutional investors were on the positive end of the spectrum even as the company has ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Hims & Hers Health's HIMS short percent of float has risen 22.07% since its last report. The company recently reported that ...